MACARTNEY LAWSON sold 25.0% of their position (16K shares) of VIKING THERAPEUTICS, INC. on the open market
Open‑market sale worth $384.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/18/2023ACC: 0001209191-23-030794
Director
Since Jan 2019
-16K
Net shares
Net seller
$384.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
16K acquired · 32K disposed
Non-Derivative Transactions2
Common Stock, par value $0.00001 per share
Direct
Shares
+16K
Price / share
$1.19
Trade value
$19.04K
% of position
33.4%
5/16/2023
47.97K→63.97K
Common Stock, par value $0.00001 per share
Direct
Shares
−16K
Price / share
$24.00
Trade value
$384K
% of position
25.0%
5/16/2023
63.97K→47.97K
Total
Net shares
+0.00
Net value
-$364.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 5/16/2023 | M · Option Exercise | +16K | $1.19 | $19.04K | 33.4% | 47.97K | 63.97K |
| Common Stock, par value $0.00001 per share Direct | 5/16/2023 | S · Sale | −16K | $24.00 | $384K | 25.0% | 63.97K | 47.97K |
| Total | +0.00 | -$364.96K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
16K shares
Shares
−16K
Strike price
1.19
Held after
0.00
Exercisable
—
5/16/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock16K shares | 5/16/2023 | M · Option Exercise | −16K | 1.19 | — | 0.00 |